ZURICH, Feb. 25, 2026 /CNW/ -- Polaroid Therapeutics (PTx) today announces that POLTX_Fiber (TM) has received the CE Mark as a Class IIb medical device with APT (TM) (Antimicrobial Polymer Technology) ...
The global wound care industry is evolving as it strives to keep up with the increasing global demand for wound care ...
Discover the top 3 undervalued Health Care Providers & Services stocks for Wednesday, February 25 based on AAII’s Stock ...
CA, UNITED STATES, February 25, 2026 / EINPresswire.com / — Medical device manufacturer WONBIOGEN (CEO Kim Won-il) is ...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended ...
POLTX_Fiber™ received its CE Mark from TüV Süd on 23rd February 2026 under MDR 2017/745. [※ Editor's note = This PRESS RELEASE was provided by the news provider, and Yonhap has not edited the content ...
Polaroid Therapeutics (PTx) today announces that POLTX_Fiber™ has received the CE Mark as a Class IIb medical device with ...
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results